SB 786 Requires health benefit plans to provide orally administered anticancer medications on a basis no less favorable than intravenously administered anticancer medications
Sponsor: Rupp
LR Number: 4398S.02P Fiscal Note: 4398-02P.ORG
Committee: Small Business, Insurance and Industry
Last Action: 4/14/2010 - Hearing Conducted H Health Care Policy Committee Journal Page:
Title: SS SB 786 Calendar Position:
Effective Date: August 28, 2010

Full Bill Text | All Actions | Available Summaries | Senate Home Page | List of 2010 Senate Bills

Current Bill Summary

SS/SB 786 - Under this act, every health benefit plan that is issued in this state that provides coverage for cancer chemotherapy treatment must provide coverage for a prescribed, orally administered anticancer medication used to kill or slow the growth of cancerous cells on a basis no less favorable than intravenously administered or injected cancer medications that are covered under the health benefit plan. The act shall not apply to certain supplemental insurance policies such as specified disease policies, Medicare supplement policies, and similar products.